Source: Annual Congress 2004 - COPD: prevalence and risk factors
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Guzelant, U. Gundogdu, C. Ar, A. S. Beliner, M. Boncu, I. Padir (Konak, Yenisehir, Turkey). Prevalence of chronic obstructive pulmonary disease(COPD) in population aged 40-69 in Konak-Izmir-Turkey. Eur Respir J 2004; 24: Suppl. 48, 2247

Member's Comments

No comment yet.

Related content which might interest you: Markers of bone metabolism in men with chronic obstructive pulmonary disease (COPD) aged 40-70 years Source: International Congress 2014 – Comorbidities Year: 2014 Prevalence of chronic obstructive pulmonary disease (COPD) in a general population in Norway Source: Annual Congress 2012 - COPD epidemiology Year: 2012 Undetected chronic obstructive pulmonary disease and asthma in people aged older than 50 presenting with cough in primary care Source: Annual Congress 2009 - Diagnostic strategies in primary respiratory care Year: 2009 Mild chronic obstructive pulmonary disease in smokers over the age of 30 Source: International Congress 2019 – Challenges in tobacco control and cessation Year: 2019 Prevalence of chronic obstructive pulmonary disease (COPD) in Greece Source: Eur Respir J 2002; 20: Suppl. 38, 122s Year: 2002 Prevalence of anxiety and depression in 196 patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - COPD comorbidities I Year: 2012 Prevalence of chronic obstructive bronchitis (COB) among French adults Source: Eur Respir J 2001; 18: Suppl. 33, 274s Year: 2001 Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers Source: Eur Respir J 2002; 20: 1117-1122 Year: 2002 Prediction of mortality in the Swiss chronic obstructive pulmonary disease (COPD) cohort using the age dyspnoe and airflow obstruction index (ADO) Source: Annual Congress 2012 - Diagnostic insights and decision making in primary care Year: 2012 Population health impact of Indacaterol/Glycopyrronium over 4 years in chronic obstructive pulmonary disease Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018 Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18–64 years old Source: Eur Respir J 2016; 48: 179-186 Year: 2016 Chronic obstructive pulmonary disease (COPD) in children: is it possible? Source: Eur Respir J 2005; 26: Suppl. 49, 63s Year: 2005 Heredity and smoking factor in relatives patients with chronic obstructive pulmonary disease - chronic obstructive bronchitis (I) and chronic nonobstructive bronchitis (II) Source: Eur Respir J 2001; 18: Suppl. 33, 214s Year: 2001 Frequency distribution of the novel GOLD-stages in newly diagnosed chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 348s Year: 2001 Prevalence of chronic obstructive pulmonary disease (COPD) in primary care Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008 Chronic obstructive pulmonary disease in 55 years old women from Germany according to GOLD stages Source: Eur Respir J 2004; 24: Suppl. 48, 359s Year: 2004 Characteristics and comorbidities associated with pain in people with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care Year: 2012 Screening study for chronic obstructive pulmonary disease among adults in Pleven Source: Annual Congress 2011 - Respiratory epidemiology: prevalence, incidence and remission Year: 2011 Functional surgery for chronic obstructive pulmonary disease: a single centre 30 years‘ experience Source: Eur Respir J 2005; 26: Suppl. 49, 490s Year: 2005 7 Years survival of patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 211s Year: 2001